Fosun Health

Founded in 2010, Shanghai Fosun Health Technology (Group) Co., Ltd. (“Fosun Health”) is a holding subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 600196.SH; 02196.HK) . Over more than a decade of steady growth, Fosun Health has established an integrated healthcare service platform centered in the Greater Bay Area, combining comprehensive and specialty hospitals with online–offline interconnected services.

Fosun Health is committed to becoming a trusted, innovative, and high-quality healthcare partner. Centered on clinical excellence, it continuously strengthens medical disciplines, advances integrated hospital group operations, and accelerates digital and primary-care connectivity. Through multi-tiered and differentiated service offerings, Fosun Health is shaping an innovative, full-lifecycle health management ecosystem that extends from prevention and diagnosis to treatment and rehabilitation.

As of June 30, 2025, Fosun Health operates and holds majority control in 19 medical institutions, including 1 Grade-A tertiary hospital, 5 tertiary grade hospitals, and 8 secondary grade hospitals, with a total of more than 6,600 beds. The Group also holds 9 Internet Hospital licenses, features 75 provincial and municipal key specialties, and has 5 hospitals accredited with dual Good Clinical Practice (GCP) certifications, reflecting its ongoing pursuit of clinical and research excellence.

Fosun Health ranked 2nd in the 2024–2025 Top 100 Private Hospital Groups in China by Ailibi GAHA, marking its fourth consecutive year among the top three. Additionally, nine hospitals under Fosun Health were listed in the 2024–2025 Top 500 Private Hospitals in China . Notably, Foshan Fosun Chancheng Hospital has held the No .1 national ranking in this category for eight consecutive years (2018–2025), underscoring Fosun Health’s leading position in China’s private healthcare sector.